Skip to content
Disclosery

Remedium Capital Partners, LLC: JBIO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Remedium Capital Partners, LLC on JBIO, newest first. How the timeline and the estimate are built.

Remedium Capital Partners, LLC held 1,577,750 JBIO shares at 2026-06-30 per its 13F-HR filed 2026-08-07.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,577,750 shares
    Change vs previous 13F 0 shares

    7.76% of the 13F portfolio, value $35,057,605.

    13F-HR 0002104501-26-000015 filed by Remedium Capital Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F/A 1,577,750 shares
    Change vs previous 13F 0 shares

    7.88% of the 13F portfolio, value $22,167,388.

    13F-HR/A 0002104501-26-000010 filed by Remedium Capital Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,577,750 shares
    Change vs previous 13F not available

    14.3% of the 13F portfolio, value $24,345,000.

    13F-HR 0002104501-26-000004 filed by Remedium Capital Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).